MedTrace Logo

Brain Stimulation for Epilepsy Long Term Follow-up

NCT00736424 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 9

Last updated 2014-01-14

No results posted yet for this study

Summary

The purpose of this study is to collect subject data to evaluate the rate of sudden unexplained death in epilepsy (SUDEP) with bilateral neurostimulation of the anterior nucleus of the thalamus in people diagnosed with refractory epilepsy. The data obtained from the physician initiated studies will be pooled with data collected in Medtronic-sponsored studies to assess SUDEP risk.

Conditions

Interventions

DEVICE

Itrel II™ and Soletra™ Epilepsy Control System

Bilateral neurostimulation of the anterior nucleus of the thalamus

Sponsors & Collaborators

  • MedtronicNeuro

    lead INDUSTRY

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-06-30
Primary Completion
2010-11-30
Completion
2010-11-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00736424 on ClinicalTrials.gov